Procyon Corporation (PCYN)

OTCMKTS · Delayed Price · Currency is USD

0.2600

0.00 (0.00%)

At close: Jul 22, 2026

36.84% (1Y)

Market Cap	2.13M +37.8%
Revenue (ttm)	4.98M +6.4%
Net Income	-312.96K
EPS	-0.04
Shares Out	8.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,975
Open	0.2600
Previous Close	n/a
Day's Range	0.2600 - 0.2600
52-Week Range	0.1000 - 0.2800
Beta	60,477.62
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Procyon

Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matr... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1987

Employees 20

Stock Exchange OTCMKTS

Ticker Symbol PCYN

Full Company Profile

Financial Performance

In fiscal year 2024, Procyon's revenue was $4.98 million, an increase of 6.35% compared to the previous year's $4.69 million. Losses were -$312,962, 367.4% more than in 2023.

Financial Statements